Table of Contents
Table of Contents 2
Introduction 12
Pancreatic Cancer Overview 13
Therapeutics Development 14
Pancreatic Cancer - Therapeutics under Development by Companies 16
Pancreatic Cancer - Therapeutics under Investigation by Universities/Institutes 42
Pancreatic Cancer - Pipeline Products Glance 45
Pancreatic Cancer - Products under Development by Companies 49
Pancreatic Cancer - Products under Investigation by Universities/Institutes 82
Pancreatic Cancer - Companies Involved in Therapeutics Development 86
Pancreatic Cancer - Therapeutics Assessment 368
Drug Profiles 437
Pancreatic Cancer - Dormant Projects 1716
Pancreatic Cancer - Discontinued Products 1746
Pancreatic Cancer - Product Development Milestones 1753
Appendix 1767
List of Tables
Number of Products under Development for Pancreatic Cancer, H1 2016 73
Number of Products under Development for Pancreatic Cancer - Comparative Analysis, H1 2016 74
Number of Products under Development by Companies, H1 2016 76
Number of Products under Development by Companies, H1 2016 (Contd..1) 77
Number of Products under Development by Companies, H1 2016 (Contd..2) 78
Number of Products under Development by Companies, H1 2016 (Contd..3) 79
Number of Products under Development by Companies, H1 2016 (Contd..4) 80
Number of Products under Development by Companies, H1 2016 (Contd..5) 81
Number of Products under Development by Companies, H1 2016 (Contd..6) 82
Number of Products under Development by Companies, H1 2016 (Contd..7) 83
Number of Products under Development by Companies, H1 2016 (Contd..8) 84
Number of Products under Development by Companies, H1 2016 (Contd..9) 85
Number of Products under Development by Companies, H1 2016 (Contd..10) 86
Number of Products under Development by Companies, H1 2016 (Contd..11) 87
Number of Products under Development by Companies, H1 2016 (Contd..12) 88
Number of Products under Development by Companies, H1 2016 (Contd..13) 89
Number of Products under Development by Companies, H1 2016 (Contd..14) 90
Number of Products under Development by Companies, H1 2016 (Contd..15) 91
Number of Products under Development by Companies, H1 2016 (Contd..16) 92
Number of Products under Development by Companies, H1 2016 (Contd..17) 93
Number of Products under Development by Companies, H1 2016 (Contd..18) 94
Number of Products under Development by Companies, H1 2016 (Contd..19) 95
Number of Products under Development by Companies, H1 2016 (Contd..20) 96
Number of Products under Development by Companies, H1 2016 (Contd..21) 97
Number of Products under Development by Companies, H1 2016 (Contd..22) 98
Number of Products under Development by Companies, H1 2016 (Contd..23) 99
Number of Products under Development by Companies, H1 2016 (Contd..24) 100
Number of Products under Investigation by Universities/Institutes, H1 2016 101
Number of Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 102
Number of Products under Investigation by Universities/Institutes, H1 2016 (Contd..2) 103
Comparative Analysis by Late Stage Development, H1 2016 104
Comparative Analysis by Clinical Stage Development, H1 2016 105
Comparative Analysis by Early Stage Development, H1 2016 106
Comparative Analysis by Unknown Stage Development, H1 2016 107
Products under Development by Companies, H1 2016 108
Products under Development by Companies, H1 2016 (Contd..1) 109
Products under Development by Companies, H1 2016 (Contd..2) 110
Products under Development by Companies, H1 2016 (Contd..3) 111
Products under Development by Companies, H1 2016 (Contd..4) 112
Products under Development by Companies, H1 2016 (Contd..5) 113
Products under Development by Companies, H1 2016 (Contd..6) 114
Products under Development by Companies, H1 2016 (Contd..7) 115
Products under Development by Companies, H1 2016 (Contd..8) 116
Products under Development by Companies, H1 2016 (Contd..9) 117
Products under Development by Companies, H1 2016 (Contd..10) 118
Products under Development by Companies, H1 2016 (Contd..11) 119
Products under Development by Companies, H1 2016 (Contd..12) 120
Products under Development by Companies, H1 2016 (Contd..13) 121
Products under Development by Companies, H1 2016 (Contd..14) 122
Products under Development by Companies, H1 2016 (Contd..15) 123
Products under Development by Companies, H1 2016 (Contd..16) 124
Products under Development by Companies, H1 2016 (Contd..17) 125
Products under Development by Companies, H1 2016 (Contd..18) 126
Products under Development by Companies, H1 2016 (Contd..19) 127
Products under Development by Companies, H1 2016 (Contd..20) 128
Products under Development by Companies, H1 2016 (Contd..21) 129
Products under Development by Companies, H1 2016 (Contd..22) 130
Products under Development by Companies, H1 2016 (Contd..23) 131
Products under Development by Companies, H1 2016 (Contd..24) 132
Products under Development by Companies, H1 2016 (Contd..25) 133
Products under Development by Companies, H1 2016 (Contd..26) 134
Products under Development by Companies, H1 2016 (Contd..27) 135
Products under Development by Companies, H1 2016 (Contd..28) 136
Products under Development by Companies, H1 2016 (Contd..29) 137
Products under Development by Companies, H1 2016 (Contd..30) 138
Products under Development by Companies, H1 2016 (Contd..31) 139
Products under Development by Companies, H1 2016 (Contd..32) 140
Products under Investigation by Universities/Institutes, H1 2016 141
Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 142
Products under Investigation by Universities/Institutes, H1 2016 (Contd..2) 143
Products under Investigation by Universities/Institutes, H1 2016 (Contd..3) 144
Pancreatic Cancer - Pipeline by 3-V Biosciences, Inc., H1 2016 145
Pancreatic Cancer - Pipeline by 4SC AG, H1 2016 146
Pancreatic Cancer - Pipeline by AB Science SA, H1 2016 147
Pancreatic Cancer - Pipeline by AbbVie Inc., H1 2016 148
Pancreatic Cancer - Pipeline by AbGenomics International, Inc., H1 2016 149
Pancreatic Cancer - Pipeline by Ability Pharmaceuticals, S.L., H1 2016 150
Pancreatic Cancer - Pipeline by Acetylon Pharmaceuticals, Inc., H1 2016 151
Pancreatic Cancer - Pipeline by ACF Pharmaceuticals, LLC, H1 2016 152
Pancreatic Cancer - Pipeline by Adamed Sp. z o.o., H1 2016 153
Pancreatic Cancer - Pipeline by Adamis Pharmaceuticals Corporation, H1 2016 154
Pancreatic Cancer - Pipeline by Aduro BioTech, Inc., H1 2016 155
Pancreatic Cancer - Pipeline by Advantagene, Inc., H1 2016 156
Pancreatic Cancer - Pipeline by Advaxis, Inc., H1 2016 157
Pancreatic Cancer - Pipeline by Agenus, Inc., H1 2016 158
Pancreatic Cancer - Pipeline by AGV Discovery, SAS, H1 2016 159
Pancreatic Cancer - Pipeline by AIMM Therapeutics B.V., H1 2016 160
Pancreatic Cancer - Pipeline by Alchemia Limited, H1 2016 161
Pancreatic Cancer - Pipeline by Alethia Biotherapeutics Inc., H1 2016 162
Pancreatic Cancer - Pipeline by Allinky Biopharma, H1 2016 163
Pancreatic Cancer - Pipeline by Almac Discovery Limited, H1 2016 164
Pancreatic Cancer - Pipeline by Altor BioScience Corporation, H1 2016 165
Pancreatic Cancer - Pipeline by Ambrx, Inc., H1 2016 166
Pancreatic Cancer - Pipeline by American Gene Technologies International Inc., H1 2016 167
Pancreatic Cancer - Pipeline by Amgen Inc., H1 2016 168
Pancreatic Cancer - Pipeline by Anavex Life Sciences Corp., H1 2016 169
Pancreatic Cancer - Pipeline by Andarix Pharmaceuticals, Inc., H1 2016 170
Pancreatic Cancer - Pipeline by ANP Technologies, Inc., H1 2016 171
Pancreatic Cancer - Pipeline by AntiCancer, Inc., H1 2016 172
Pancreatic Cancer - Pipeline by APEIRON Biologics AG, H1 2016 173
Pancreatic Cancer - Pipeline by Aphios Corporation, H1 2016 174
Pancreatic Cancer - Pipeline by APIM Therapeutics AS, H1 2016 175
Pancreatic Cancer - Pipeline by Apogenix GmbH, H1 2016 176
Pancreatic Cancer - Pipeline by Aposense Ltd., H1 2016 177
Pancreatic Cancer - Pipeline by ArQule, Inc., H1 2016 178
Pancreatic Cancer - Pipeline by Array BioPharma Inc., H1 2016 179
Pancreatic Cancer - Pipeline by Astellas Pharma Inc., H1 2016 180
Pancreatic Cancer - Pipeline by AstraZeneca Plc, H1 2016 181
Pancreatic Cancer - Pipeline by ATLAB Pharma SAS, H1 2016 182
Pancreatic Cancer - Pipeline by Aurigene Discovery Technologies Limited, H1 2016 183
Pancreatic Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H1 2016 184
Pancreatic Cancer - Pipeline by Axcentua Pharmaceuticals AB, H1 2016 185
Pancreatic Cancer - Pipeline by Azaya Therapeutics, Inc., H1 2016 186
Pancreatic Cancer - Pipeline by Basilea Pharmaceutica AG, H1 2016 187
Pancreatic Cancer - Pipeline by Bavarian Nordic A/S, H1 2016 188
Pancreatic Cancer - Pipeline by Bayer AG, H1 2016 189
Pancreatic Cancer - Pipeline by Bellicum Pharmaceuticals, Inc., H1 2016 190
Pancreatic Cancer - Pipeline by Berg LLC, H1 2016 191
Pancreatic Cancer - Pipeline by BerGenBio AS, H1 2016 192
Pancreatic Cancer - Pipeline by Betta Pharmaceuticals Co. Ltd., H1 2016 193
Pancreatic Cancer - Pipeline by Bexion Pharmaceuticals, LLC., H1 2016 194
Pancreatic Cancer - Pipeline by Biomar Microbial Technologies, H1 2016 195
Pancreatic Cancer - Pipeline by Biomunex Pharmaceuticals, H1 2016 196
Pancreatic Cancer - Pipeline by Bioncotech Therapeutics S.L., H1 2016 197
Pancreatic Cancer - Pipeline by Bionomics Limited, H1 2016 198
Pancreatic Cancer - Pipeline by BioNTech AG, H1 2016 199
Pancreatic Cancer - Pipeline by BiOrion Technologies B.V., H1 2016 200
Pancreatic Cancer - Pipeline by Biotest AG, H1 2016 201
Pancreatic Cancer - Pipeline by Biouniversa s.r.l., H1 2016 202
Pancreatic Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2016 203
Pancreatic Cancer - Pipeline by Boston Biomedical, Inc., H1 2016 204
Pancreatic Cancer - Pipeline by Bristol-Myers Squibb Company, H1 2016 205
Pancreatic Cancer - Pipeline by Cadila Pharmaceuticals Limited, H1 2016 206
Pancreatic Cancer - Pipeline by Calithera Biosciences, Inc., H1 2016 207
Pancreatic Cancer - Pipeline by Cantargia AB, H1 2016 208
Pancreatic Cancer - Pipeline by Cascadian Therapeutics Inc, H1 2016 209
Pancreatic Cancer - Pipeline by Cavion LLC, H1 2016 210
Pancreatic Cancer - Pipeline by Celgene Corporation, H1 2016 211
Pancreatic Cancer - Pipeline by Cellceutix Corporation, H1 2016 212
Pancreatic Cancer - Pipeline by Cellectis S.A., H1 2016 213
Pancreatic Cancer - Pipeline by Cellular Biomedicine Group, Inc., H1 2016 214
Pancreatic Cancer - Pipeline by Celprogen, Inc., H1 2016 215
Pancreatic Cancer - Pipeline by Celsion Corporation, H1 2016 216
Pancreatic Cancer - Pipeline by Centrose LLC, H1 2016 217
Pancreatic Cancer - Pipeline by Ceronco Biosciences, H1 2016 218
Pancreatic Cancer - Pipeline by ChemoCentryx, Inc., H1 2016 219
Pancreatic Cancer - Pipeline by Chiome Bioscience, Inc., H1 2016 220
Pancreatic Cancer - Pipeline by Clovis Oncology, Inc., H1 2016 221
Pancreatic Cancer - Pipeline by Coare Biotechnology, Inc., H1 2016 222
Pancreatic Cancer - Pipeline by Concordia Healthcare Corp., H1 2016 223
Pancreatic Cancer - Pipeline by Confluence Life Sciences, Inc., H1 2016 224
Pancreatic Cancer - Pipeline by Cornerstone Pharmaceuticals, Inc., H1 2016 225
Pancreatic Cancer - Pipeline by Critical Outcome Technologies Inc., H1 2016 226
Pancreatic Cancer - Pipeline by CritiTech, Inc., H1 2016 227
Pancreatic Cancer - Pipeline by CrystalGenomics, Inc., H1 2016 228
Pancreatic Cancer - Pipeline by CTI BioPharma Corp., H1 2016 229
Pancreatic Cancer - Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2016 230
Pancreatic Cancer - Pipeline by CytomX Therapeutics, Inc., H1 2016 231
Pancreatic Cancer - Pipeline by CytRx Corporation, H1 2016 232
Pancreatic Cancer - Pipeline by CyTuVax B.V., H1 2016 233
Pancreatic Cancer - Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2016 234
Pancreatic Cancer - Pipeline by DEKK-TEC, Inc., H1 2016 235
Pancreatic Cancer - Pipeline by Dicerna Pharmaceuticals, Inc., H1 2016 236
Pancreatic Cancer - Pipeline by Diffusion Pharmaceuticals Inc., H1 2016 237
Pancreatic Cancer - Pipeline by Eisai Co., Ltd., H1 2016 238
Pancreatic Cancer - Pipeline by Eleison Pharmaceuticals LLC, H1 2016 239
Pancreatic Cancer - Pipeline by Eli Lilly and Company, H1 2016 240
Pancreatic Cancer - Pipeline by Endor Nanotechnologies SL, H1 2016 241
Pancreatic Cancer - Pipeline by Ensol Biosciences Inc., H1 2016 242
Pancreatic Cancer - Pipeline by Erytech Pharma SA, H1 2016 243
Pancreatic Cancer - Pipeline by Esperance Pharmaceuticals, Inc., H1 2016 244
Pancreatic Cancer - Pipeline by Etubics Corporation, H1 2016 245
Pancreatic Cancer - Pipeline by Exelixis, Inc., H1 2016 246
Pancreatic Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H1 2016 247
Pancreatic Cancer - Pipeline by FibroGen, Inc., H1 2016 248
Pancreatic Cancer - Pipeline by Five Prime Therapeutics, Inc., H1 2016 249
Pancreatic Cancer - Pipeline by Forty Seven Inc., H1 2016 250
Pancreatic Cancer - Pipeline by Fountain Biopharma Inc., H1 2016 251
Pancreatic Cancer - Pipeline by Fujifilm Corporation, H1 2016 252
Pancreatic Cancer - Pipeline by Fusion Antibodies Limited, H1 2016 253
Pancreatic Cancer - Pipeline by GamaMabs Pharma S.A., H1 2016 254
Pancreatic Cancer - Pipeline by Ganymed Pharmaceuticals AG, H1 2016 255
Pancreatic Cancer - Pipeline by Geistlich Pharma AG, H1 2016 256
Pancreatic Cancer - Pipeline by Genelux Corporation, H1 2016 257
Pancreatic Cancer - Pipeline by Genentech, Inc., H1 2016 258
Pancreatic Cancer - Pipeline by Genisphere Inc., H1 2016 259
Pancreatic Cancer - Pipeline by Genmab A/S, H1 2016 260
Pancreatic Cancer - Pipeline by Gilead Sciences, Inc., H1 2016 261
Pancreatic Cancer - Pipeline by GlaxoSmithKline Plc, H1 2016 262
Pancreatic Cancer - Pipeline by Globeimmune, Inc., H1 2016 263
Pancreatic Cancer - Pipeline by GlycoMimetics, Inc., H1 2016 264
Pancreatic Cancer - Pipeline by Golden Biotechnology Corp., H1 2016 265
Pancreatic Cancer - Pipeline by GW Pharmaceuticals Plc, H1 2016 266
Pancreatic Cancer - Pipeline by Halozyme Therapeutics, Inc., H1 2016 267
Pancreatic Cancer - Pipeline by HEC Pharm Co., Ltd., H1 2016 268
Pancreatic Cancer - Pipeline by Helix BioPharma Corp., H1 2016 269
Pancreatic Cancer - Pipeline by iCeutica, Inc., H1 2016 270
Pancreatic Cancer - Pipeline by Ignyta, Inc., H1 2016 271
Pancreatic Cancer - Pipeline by Immodulon Therapeutics Ltd., H1 2016 272
Pancreatic Cancer - Pipeline by Immune Pharmaceuticals Inc., H1 2016 273
Pancreatic Cancer - Pipeline by Immune System Key Ltd., H1 2016 274
Pancreatic Cancer - Pipeline by Immunomedics, Inc., H1 2016 275
Pancreatic Cancer - Pipeline by Immunotope, Inc., H1 2016 276
Pancreatic Cancer - Pipeline by Immunovo BV, H1 2016 277
Pancreatic Cancer - Pipeline by Immupharma Plc, H1 2016 278
Pancreatic Cancer - Pipeline by Incuron, LLC, H1 2016 279
Pancreatic Cancer - Pipeline by Incyte Corporation, H1 2016 280
Pancreatic Cancer - Pipeline by Inflection Biosciences Limited, H1 2016 281
Pancreatic Cancer - Pipeline by Innopharmax Inc., H1 2016 282
Pancreatic Cancer - Pipeline by Inovio Pharmaceuticals, Inc., H1 2016 283
Pancreatic Cancer - Pipeline by Intica Biomedical, Inc., H1 2016 284
Pancreatic Cancer - Pipeline by Inventiva, H1 2016 285
Pancreatic Cancer - Pipeline by Io Therapeutics, Inc., H1 2016 286
Pancreatic Cancer - Pipeline by Ipsen S.A., H1 2016 287
Pancreatic Cancer - Pipeline by Jasco Pharmaceuticals, LLC., H1 2016 288
Pancreatic Cancer - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H1 2016 289
Pancreatic Cancer - Pipeline by Johnson & Johnson, H1 2016 290
List of Figures
Number of Products under Development for Pancreatic Cancer, H1 2016 73
Number of Products under Development for Pancreatic Cancer - Comparative Analysis, H1 2016 74
Number of Products under Development by Companies, H1 2016 75
Number of Products under Investigation by Universities/Institutes, H1 2016 101
Comparative Analysis by Late Stage Development, H1 2016 104
Comparative Analysis by Clinical Stage Development, H1 2016 105
Comparative Analysis by Early Stage Products, H1 2016 106
Assessment by Monotherapy Products, H1 2016 427
Assessment by Combination Products, H1 2016 428
Number of Products by Top 10 Targets, H1 2016 429
Number of Products by Stage and Top 10 Targets, H1 2016 429
Number of Products by Top 10 Mechanism of Actions, H1 2016 462
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 462
Number of Products by Top 10 Routes of Administration, H1 2016 492
Number of Products by Stage and Top 10 Routes of Administration, H1 2016 492
Number of Products by Top 10 Molecule Types, H1 2016 494
Number of Products by Stage and Top 10 Molecule Types, H1 2016 494